10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
39.01
-0.04 (-0.10%)
At close: Jul 2, 2026, 4:00 PM EDT
39.08
+0.07 (0.18%)
After-hours: Jul 2, 2026, 7:06 PM EDT
10x Genomics Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, 10x Genomics stock has a consensus rating of "Buy" and an average price target of $27.62. The average 1-year stock price forecast is 29.20% lower than the current stock price, while the lowest is $20 (-48.73%) and the highest is $40 (+2.54%).
Price Target: $27.62 (-29.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for 10x Genomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 12 | 12 | 10 | 10 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $20 → $42 | Hold | Reiterates | $20 → $42 | +7.66% | Jul 1, 2026 |
| Barclays | Barclays | Buy Reiterates $30 → $40 | Buy | Reiterates | $30 → $40 | +2.54% | Jun 24, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $32 | Buy | Reiterates | $32 | -17.97% | Jun 10, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 14, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $22 | Hold | Maintains | $20 → $22 | -43.60% | May 12, 2026 |
Financial Forecast
Revenue This Year
613.80M
from 642.82M
Decreased by -4.51%
Revenue Next Year
669.25M
from 613.80M
Increased by 9.03%
EPS This Year
n/a
from 0.12
Decreased by -100.00%
EPS Next Year
0.20
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 623.2M | ||
| Avg | 613.8M | ||
| Low | 605.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.1% | ||
| Avg | -4.5% | ||
| Low | -5.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.06 | ||
| Avg | - | ||
| Low | -0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -51.3% | ||
| Avg | -100.0% | ||
| Low | - |